Although historical data is somewhat mixed and not specifically focused on the elderly, studies broadly show that G-CSF reduces neutropenia and infection, enabling retention of relative dose intensity (RDI) without impacting OS [60–62]. The gene discussed is CSF3; the disease is Decreased total neutrophil count.